Watchlist Price Alert

Scinai Immunotherapeutics... (SCNI)

NASDAQ: SCNI · Real-Time Price · USD

2.18

-0.09 (-3.96%)

At close: Jul 03, 2025, 2:39 PM

Scinai Immunotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-6.5M	-5.8M	-8.21M	-1.3M	-31.62M	-23.46M	-9.93M	-2.38M
Depreciation & Amortization	514K	562K	471K	757.91K	476.36K	69.53K	126.45K	162.32K
Stock-Based Compensation	1.14M	1.6M	2.76M	2.95M	1.07M	69.53K	149.16K	327.29K
Other Working Capital	-356K	306K	650.85K	366.51K	36.78K	111.24K	-8.33K	-21.68K
Other Non-Cash Items	-3.89M	-4.08M	-3.15M	-25.17M	7.64M	7.12M	7.67M	-756.95K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-646K	446K	701K	196.01K	126.26K	902.23K	-901.54K	145.61K
Operating Cash Flow	-9.38M	-7.26M	-7.43M	-22.57M	-22.31M	-15.29M	-2.89M	-2.51M
Capital Expenditures	-637K	-836K	-133.12K	-1.91M	-2.15M	-6.35M	-1.3M	-5.19K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	-112.63K	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	61.29K	66.6K	74.07K	3.35M	-2.02M
Investing Cash Flow	-637K	-836K	-139K	-1.85M	-2.08M	-6.27M	1.94M	-2.03M
Debt Repayment	n/a	n/a	n/a	-385.8K	4.27M	22.55M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	947K	6.78M	21.43M	4.65M	20.4M	n/a	17.77M	n/a
Financial Cash Flow	1.09M	6.78M	21.43M	4.27M	24.68M	22.55M	17.77M	n/a
Net Cash Flow	-9.21M	-3.3M	14.59M	-18.05M	693.11K	-222.68K	16.44M	-4.51M
Free Cash Flow	-10.02M	-8.1M	-7.57M	-24.48M	-24.47M	-21.64M	-4.18M	-2.51M